Filing Summary
Issuer: Flora Growth Corp. The supplied filing is a Form 6-K for the month of March 2022, filed March 17, 2022. The request metadata identifies Zerostack Corp., but the filing names Flora Growth Corp. as the registrant.
Business Context and Reporting Period
This Form 6-K reports changes to the company’s board and Audit Committee. It does not present quarterly or annual operating results.
Key Financial Metrics and Liquidity
The filing does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics.
Under a consulting agreement effective March 15, 2022, Dr. Bernard Wilson will provide advisory services through December 31, 2022 for compensation of $25,000 per month. The agreement may be terminated by either party subject to certain conditions.
Material Changes Versus the Prior Comparable Period
- Dr. Bernard Wilson resigned from the Board and as Chairman and a member of the Audit Committee effective March 10, 2022. The filing states that the resignation was not due to disagreements with the company or Board.
- Effective March 15, 2022, CEO and director Luis Merchan became Chairman of the Board.
- John Timothy “Tim” Leslie was appointed as a director and Audit Committee member effective March 15, 2022.
- The Board determined that Mr. Leslie qualifies as an audit committee financial expert, is financially literate, and satisfies applicable independence requirements.
Outlook, Risks, Contingencies, and Unusual Items
- The disclosed consulting arrangement creates a monthly advisory expense of $25,000 through December 31, 2022, subject to termination provisions.
- No financial guidance, operating outlook, material contingencies, or broader risk updates are provided in the filing.
- The filing states that the company had no material interested transaction with Mr. Leslie exceeding or expected to exceed $120,000 since the beginning of the last fiscal year.
- Mr. Leslie has prior executive experience at Leafly and Amazon.com and serves on the boards of Endocanna Health and New Frontier Data.
Investor Verification Items
- Verify the issuer identity, because the request metadata names Zerostack Corp. while the filing names Flora Growth Corp.
- Review the consulting agreement’s termination conditions and total expected compensation.
- Confirm the composition, independence, and financial expertise of the reconstituted Audit Committee.
- Review Exhibit 99.1, the March 17, 2022 press release, for any additional governance information.
- Consult the company’s subsequent filings for any effects of the leadership and committee changes on financial reporting or strategy.